Respironics News (NASDAQ:RESP)
| Latest Respironics News Headlines | | Date | Time | Source | | | 03/06/2008 | 6:05PM | PRNUS | QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Inde
NEW YORK, March 6 /PRNewswire/ -- QED International Associates, Inc, administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced that effective at the opening of trading on March 11, 2008, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY... More...>> |
| 01/24/2008 | 7:30AM | PRNUS | Respironics Reports Record Financial Results for Fiscal Year 2008 Second Quarter, Comments on Previously Announced Merger Agreem
MURRYSVILLE, Pa., Jan. 24 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced record financial results for the three months and six months ended December 31, 2007.
FINANCIAL RESULTS
Three Months Ended December 31, 2007
Net sales for the second quarter totaled $343.1 million, which represents... More...>> |
| 12/26/2007 | 12:28PM | PRNUS | Featured Stocks on Today's Edition of the Analyst's Review: RESP, RMD, IVC, SYK
NEW YORK, Dec. 26 /PRNewswire/ -- The Analyst's Review is a daily podcast hosted by WallSt.net editor, Henry Truc that airs every morning at 9 a.m. EST on http://radio.wallst.net/profile.asp?id=193.
The show features informative interviews with Wall Street analysts on a wide range of topics including actively traded... More...>> |
| 12/21/2007 | 2:15AM | PRNUS | Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
MURRYSVILLE, Pa., Dec. 21 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced it has entered into a definitive merger agreement pursuant to which Royal Philips Electronics (AEX:PHIAEX:NYSE:AEX:PHG) (Philips) will commence a tender offer to acquire all of the outstanding shares of Respironics for... More...>> |
| 10/25/2007 | 7:00AM | PRNUS | Respironics Reports Record Financial Results for Fiscal Year 2008 First Quarter, Achieves 20 Percent Global Sleep Therapy Revenu
MURRYSVILLE, Pa., Oct. 25 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced record financial results for the three months ended September 30, 2007.
FINANCIAL RESULTS
Three Months Ended September 30, 2007
Net sales for the first quarter totaled $311.6 million, which represents an increase... More...>> |
| 10/17/2007 | 9:00AM | PRNUS | Respironics to Webcast Fiscal 2008 First Quarter Conference Call
MURRYSVILLE, Penn., Oct. 17 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP), a recognized resource in the medical device market, announced today that it intends to release its first quarter results for the period ending September 30, 2007 on Thursday October 25, 2007. In conjunction with this release and to... More...>> |
| 10/08/2007 | 11:14AM | PRNUS | Dixtal Medical Purchases Novametrix Pulse Oximetry Business from Respironics
MURRYSVILLE, Pa., Oct. 8 /PRNewswire-FirstCall/ -- Dixtal Medical, Inc. and Respironics, Inc. (NASDAQ:RESP) announced today that Dixtal Medical has acquired the Novametrix pulse oximetry product line from Respironics. This pulse oximetry product line will be marketed under the Dixtal/Novametrix brand pursuant to Dixtal... More...>> |
| 10/02/2007 | 7:59AM | PRNUS | Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
MURRYSVILLE, Pa., Oct. 2 /PRNewswire/ -- Respironics, Inc. (NASDAQ:RESP) today announced that it has acquired 100% of the outstanding shares of Apollo Light Systems, Inc., a 20-year-old, privately held company and a leading manufacturer of light therapy systems for melatonin suppression and circadian rhythm sleep disorders... More...>> |
| 07/25/2007 | 4:00PM | PRNUS | Respironics Reports Record Financial Results for Fiscal Year 2007 Fourth Quarter and Full Year, Achieves 21 Percent Global Sleep
MURRYSVILLE, Pa., July 25 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced record financial results for the three months and fiscal year ended June 30, 2007.
FINANCIAL RESULTS
Three Months Ended June 30, 2007
Net sales for the fourth quarter totaled $332.4 million, which represents an... More...>> |
| 07/12/2007 | 9:00AM | PRNUS | Respironics to Webcast Fiscal 2007 Fourth Quarter and Year End Conference Call
MURRYSVILLE, Pa., July 12 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP), a recognized resource in the medical device market, announced today that it intends to release its fourth quarter and year end results for the period ending June 30, 2007 on Wednesday, July 25, 2007. In conjunction with this release... More...>> |
| 04/26/2007 | 6:59AM | PRNUS | Respironics Reports Record Financial Results for Fiscal Year 2007 Third Quarter, Achieves 21 Percent Global Sleep Therapy Revenu
MURRYSVILLE, Pa., April 26 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced record financial results for the three months and nine months ended March 31, 2007.
FINANCIAL RESULTS
Three Months Ended March 31, 2007
Net sales for the third quarter totaled $307.4 million, up 15 percent over... More...>> |
| 04/24/2007 | 7:00AM | PRNUS | Respironics Showcases Latest Technologies at Medtrade Spring; Building Upon Strong Fiscal Third Quarter Performance, Announces A
MURRYSVILLE, Pa., April 24 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP) will showcase its latest innovations for sleep and home respiratory care at Medtrade Spring 2007. The international tradeshow for the home healthcare industry kicks off tomorrow at the Las Vegas Convention Center. Innovative sleep... More...>> |
| 04/12/2007 | 9:00AM | PRNUS | Respironics to Webcast Fiscal 2007 Third Quarter Conference Call
MURRYSVILLE, Pa., April 12 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP), a recognized resource in the medical device market, announced today that it intends to release its third quarter results for the period ending March 31, 2007 on Thursday, April 26, 2007. In conjunction with this release and to review... More...>> |
| 03/16/2007 | 10:30AM | PRNUS | Respironics' I-neb(R) Device Utilized in Clinical Evaluation Of Interferon Gamma in Idiopathic Pulmonary Fibrosis Patients
MURRYSVILLE, Pa., March 16 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP) today announced that it has formed an agreement with The State University of New York (SUNY) and New York University School of Medicine (NYU) to utilize the I-neb Adaptive Aerosol Delivery (AAD(R)) System for clinical evaluation of... More...>> |
| 03/07/2007 | 8:30AM | PRNUS | Respironics Receives 510(k) Clearance from FDA for BiPAP(R) autoSV(TM) Device Designed for Complicated Sleep-Disordered Breathin
MURRYSVILLE, Pa., March 7 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP) today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance of the BiPAP autoSV device, which is intended to provide noninvasive ventilatory support to treat adult patients with Obstructive Sleep Apnea (OSA... More...>> |
| 01/29/2007 | 10:00AM | PRNUS | Respironics to Webcast Analyst Day Presentations on Thursday, February 1, 2007
MURRYSVILLE, Pa., Jan. 29 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP), a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets, is scheduled to host an Analyst Day in New York City on Thursday, February 1, 2007 beginning... More...>> |
| 01/25/2007 | 6:58AM | PRNUS | Respironics Reports Record Financial Results for Fiscal Year 2007 Second Quarter, M-series CPAP Fully Launched, OptiLife(TM) Pat
MURRYSVILLE, Pa., Jan. 25 /PRNewswire-FirstCall/ -- RESPIRONICS, INC. (NASDAQ:RESP) today announced record financial results for the three months and six months ended December 31, 2006.
FINANCIAL RESULTS
Three Months Ended December 31, 2006
Net sales for the second quarter totaled $288.7 million, up 12 percent... More...>> |
| 01/12/2007 | 8:00AM | PRNUS | Respironics to Webcast Fiscal 2007 Second Quarter Conference Call
MURRYSVILLE, Pa., Jan. 12 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP), a recognized resource in the medical device market, announced today that it intends to release its second quarter results for the period ending December 31, 2006 on Thursday January 25, 2007. In conjunction with this release and to... More...>> |
| 12/08/2006 | 9:05AM | PRNUS | Axeda Presents Respironics with Remote Service Leadership Award
Market leading Respi-Link(TM) remote service program wins top honors
FOXBORO, Mass., Dec. 8 /PRNewswire/ -- Axeda Corporation, the leading provider of remote product service and support software, today announced that Respironics, Inc. (NASDAQ:RESP) was presented with Axeda's first annual Remote Service Leadership Award... More...>> |
| 10/26/2006 | 7:00AM | PRNUS | Respironics Reports Record Financial Results for Fiscal Year 2007 First Quarter, Achieves 17 Percent Global Sleep Therapy Growth
MURRYSVILLE, Pa., Oct. 26 /PRNewswire-FirstCall/ -- Respironics, Inc. (NASDAQ:RESP) today announced record financial results for the three months ended September 30, 2006.
FINANCIAL RESULTS
Three Months Ended September 30, 2006
Net sales for the first quarter totaled $266.6 million, up 11 percent over the $240.2... More...>> |
|
|
|